We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Dozens of healthcare organizations, including several device makers, wrote an open letter to President Donald Trump urging him and Congress to continue the pursuit of value-based care. Read More
The FDA has reclassified antigen-based rapid influenza virus antigen detection test systems (RIDTs) from Class I to Class II devices and has introduced special controls aimed at improving the quality of testing. Read More